🇺🇸 FDA
Patent

US 11779565

Small organic molecules for use in the treatment of neuroinflammatory disorders

granted A61KA61K31/165A61K31/345

Quick answer

US patent 11779565 (Small organic molecules for use in the treatment of neuroinflammatory disorders) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
Grant date
Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/165, A61K31/345, A61K31/381, A61K31/395